Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2020-04-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-020-15532-1 |
_version_ | 1818400496317104128 |
---|---|
author | Zhichen Sun Zhenhua Ren Kaiting Yang Zhida Liu Shuaishuai Cao Sisi Deng Lily Xu Yong Liang Jingya Guo Yingjie Bian Hairong Xu Jiyun Shi Fan Wang Yang-Xin Fu Hua Peng |
author_facet | Zhichen Sun Zhenhua Ren Kaiting Yang Zhida Liu Shuaishuai Cao Sisi Deng Lily Xu Yong Liang Jingya Guo Yingjie Bian Hairong Xu Jiyun Shi Fan Wang Yang-Xin Fu Hua Peng |
author_sort | Zhichen Sun |
collection | DOAJ |
description | An amendment to this paper has been published and can be accessed via a link at the top of the paper. |
first_indexed | 2024-12-14T07:37:30Z |
format | Article |
id | doaj.art-eb1092bb98ea40d8a68e6eb6d71dcefc |
institution | Directory Open Access Journal |
issn | 2041-1723 |
language | English |
last_indexed | 2024-12-14T07:37:30Z |
publishDate | 2020-04-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Nature Communications |
spelling | doaj.art-eb1092bb98ea40d8a68e6eb6d71dcefc2022-12-21T23:11:08ZengNature PortfolioNature Communications2041-17232020-04-011111110.1038/s41467-020-15532-1Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor controlZhichen Sun0Zhenhua Ren1Kaiting Yang2Zhida Liu3Shuaishuai Cao4Sisi Deng5Lily Xu6Yong Liang7Jingya Guo8Yingjie Bian9Hairong Xu10Jiyun Shi11Fan Wang12Yang-Xin Fu13Hua Peng14Key Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesDepartment of Pathology, University of Texas Southwestern Medical CenterKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesDepartment of Pathology, University of Texas Southwestern Medical CenterKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesUniversity of Chinese Academy of SciencesDepartment of Biological Sciences, University of Wellesley CollegeKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of SciencesKey Laboratory of Protein and Peptide Pharmaceuticals, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of SciencesDepartment of Pathology, University of Texas Southwestern Medical CenterKey Laboratory of Infection and Immunity of CAS, Institute of Biophysics, Chinese Academy of SciencesAn amendment to this paper has been published and can be accessed via a link at the top of the paper.https://doi.org/10.1038/s41467-020-15532-1 |
spellingShingle | Zhichen Sun Zhenhua Ren Kaiting Yang Zhida Liu Shuaishuai Cao Sisi Deng Lily Xu Yong Liang Jingya Guo Yingjie Bian Hairong Xu Jiyun Shi Fan Wang Yang-Xin Fu Hua Peng Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control Nature Communications |
title | Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control |
title_full | Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control |
title_fullStr | Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control |
title_full_unstemmed | Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control |
title_short | Author Correction: A next-generation tumor-targeting IL-2 preferentially promotes tumor-infiltrating CD8+ T-cell response and effective tumor control |
title_sort | author correction a next generation tumor targeting il 2 preferentially promotes tumor infiltrating cd8 t cell response and effective tumor control |
url | https://doi.org/10.1038/s41467-020-15532-1 |
work_keys_str_mv | AT zhichensun authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT zhenhuaren authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT kaitingyang authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT zhidaliu authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT shuaishuaicao authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT sisideng authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT lilyxu authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT yongliang authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT jingyaguo authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT yingjiebian authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT hairongxu authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT jiyunshi authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT fanwang authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT yangxinfu authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol AT huapeng authorcorrectionanextgenerationtumortargetingil2preferentiallypromotestumorinfiltratingcd8tcellresponseandeffectivetumorcontrol |